Column Capital Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Column Capital Advisors’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$51.6K	Hold	102	–	–	0.01%	320
2023 Q2	$53.2K	Hold	102	–	–	0.01%	314
2023 Q1	$58.8K	Buy	102 +68	+200%	+$38.3K	0.01%	300
2022 Q4	$18.7K	Hold	34	–	–	﹤0.01%	429
2022 Q3	$17K	Hold	34	–	–	﹤0.01%	408
2022 Q2	$18K	Hold	34	–	–	﹤0.01%	404
2022 Q1	$20K	Sell	34 -4	-11%	-$2.3K	﹤0.01%	411
2021 Q4	$25K	Buy	38 +2	+6%	+$1.25K	﹤0.01%	390
2021 Q3	$21K	Hold	36	–	–	﹤0.01%	376
2021 Q2	$18K	Hold	36	–	–	﹤0.01%	399
2021 Q1	$16K	Hold	36	–	–	﹤0.01%	399
2020 Q4	$17K	Sell	36 -39	-52%	-$18.3K	﹤0.01%	394
2020 Q3	$33K	Buy	75 +39	+108%	+$16.1K	0.01%	305
2020 Q2	$13K	Hold	36	–	–	﹤0.01%	440
2020 Q1	$10K	Buy	36 +23	+177%	+$7.25K	﹤0.01%	398
2019 Q4	$4K	Buy	+13	New	+$3.94K	﹤0.01%	551

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Column Capital Advisors's TMO Position: Q3 2023 in Review

Column Capital Advisors held its Thermo Fisher Scientific (TMO) position steady in Q3 2023 at 102 shares worth $51.6K. The position accounts for 0.01% of the portfolio, ranked #320.

Column Capital Advisors first reported a position in TMO in Q4 2019 and has held it in 16 quarters since. The position peaked at $58.8K in Q1 2023. 2,364 funds tracked by Wall St. Rank hold TMO as of Q3 2023.

Column Capital Advisors held 102 shares of Thermo Fisher Scientific worth $51.6K as of Q3 2023.
Column Capital Advisors left its Thermo Fisher Scientific share count unchanged in Q3 2023.
Thermo Fisher Scientific made up 0.01% of Column Capital Advisors's portfolio in Q3 2023, its #320 holding.
Column Capital Advisors first reported a position in Thermo Fisher Scientific in Q4 2019 and has held it in 16 quarters since.
Column Capital Advisors's Thermo Fisher Scientific position peaked at $58.8K in Q1 2023.
2,364 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2023.

Based on Column Capital Advisors's 13F filing for Q3 2023, filed 3 Nov 2023.